Echocardiographic alterations in patients with chronic kidney failure undergoing hemodialysis;Alteraciones ecocardiográficas en pacientes con insuficiencia renal crónica en programa de hemodiálisis

Arquivos Brasileiros de Cardiologia

Volumn 94, Issue 1, 2010, Pages 131-137

  Barberato, Silvio Henrique ^a   Pecoits Filho, Roberto ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

Echocardiography, Doppler; Renal Dialysis; Risk Assessment

Indexed keywords

ERYTHROPOIETIN;

AORTA STENOSIS; ARTERIOSCLEROSIS; BODY MASS; CARDIOVASCULAR RISK; CARDIOVASCULAR SYSTEM EXAMINATION; CEREBROVASCULAR ACCIDENT; CHRONIC INFLAMMATION; CHRONIC KIDNEY DISEASE; CHRONIC KIDNEY FAILURE; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DOPPLER ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART ARRHYTHMIA; HEART ATRIUM ENLARGEMENT; HEART ATRIUM FIBRILLATION; HEART DEATH; HEART DISEASE; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE FILLING PRESSURE; HEART LEFT VENTRICLE OVERLOAD; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART VENTRICLE COMPLIANCE; HEART VENTRICLE HYPERTROPHY; HEART VOLUME; HEMATOCRIT; HEMODIALYSIS; HUMAN; HYPERPARATHYROIDISM; HYPERTENSION; ISCHEMIC HEART DISEASE; KIDNEY GRAFT; MAJOR CLINICAL STUDY; MALNUTRITION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PERICARDIAL DISEASE; PREVALENCE; PROGNOSIS; REVIEW; STRESS ECHOCARDIOGRAPHY; SUDDEN DEATH; SURVIVAL; UREMIA; VALVULAR HEART DISEASE;

EID: 77951554685     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: None     Document Type: Review

References (68)

1. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003; 108: 2154-2169 (Pubitemid 37337595)
2. London GM. Cardiovascular disease in chronic renal failure: pathophysiologic aspects. Semin Dial. 2003; 16: 85-94. (Pubitemid 37356820)
3. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998; 32: S112-9.
4. Foley RN, Herzog CA, Collins AJ. Smoking and cardiovascular outcomes in dialysis patients: the United States Renal Data System Wave 2 study. Kidney Int. 2003; 63: 1462-1467
5. Stenvinkel P, Pecoits-Filho R, Lindholm B. Coronary artery disease in end-stage renal disease: no longer a simple plumbing problem. J Am Soc Nephrol. 2003; 14: 1927-1939
6. McCullough PA. Cardiovascular disease in chronic kidney disease from a cardiologist's perspective. Curr Opin Nephrol Hypertens. 2004; 13: 591-600.
7. Parfrey PS, Foley RN. The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol. 1999; 10: 1606-1615
8. Silverberg DS, Wexler D, Iaina A, Steinbruch S, Wollman Y, Schwartz D. Anemia, chronic renal disease and congestive heart failure - the cardio renal anemia syndrome: the need for cooperation between cardiologists and nephrologists. Int Urol Nephrol. 2006; 38: 295-310.
9. Palazzuoli A, Silverberg DS, Iovine F, Calabro A, Campagna MS, Gallotta M, et al. Effects of beta-erythropoietin treatment on left ventricular remodeling, systolic function, and B-type natriuretic peptide levels in patients with the cardiorenal anemia syndrome. Am Heart J. 2007; 154: 645 e9-15.
10. Ritz E, Rambausek M, Mall G, Ruffmann K, Mandelbaum A. Cardiac changes in urAImia and their possible relationship to cardiovascular instability on dialysis. Nephrol Dial Transplant. 1990; 5 (Suppl 1): 93-97
11. Parfrey PS, Harnett JD, Foley RN. Heart failure and ischemic heart disease in chronic uremia. Curr Opin Nephrol Hypertens. 1995; 4: 105-110
12. Herzog CA. Sudden cardiac death and acute myocardial infarction in dialysis patients: perspectives of a cardiologist. Semin Nephrol. 2005; 25: 363-366
13. London GM. Left ventricular alterations and end-stage renal disease. Nephrol Dial Transplant. 2002; 17 (Suppl 1): 29-36.
14. Foley RN, Parfrey PS, Harnett JD, Kent GM, Martin CJ, Murray DC, et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int. 1995; 47: 186-192
15. Yamada H, Goh PP, Sun JP, Odabashian J, Garcia MJ, Thomas JD, et al. Prevalence of left ventricular diastolic dysfunction by Doppler echocardiography: clinical application of the Canadian consensus guidelines. J Am Soc Echocardiogr. 2002; 15: 1238-1244
16. Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray D, Barre PE. Outcome and risk factors of ischemic heart disease in chronic uremia. Kidney Int. 1996; 49: 1428-1434 (Pubitemid 26166417)
17. Kunz K, Dimitrov Y, Muller S, Chantrel F, Hannedouche T. Uraemic cardiomyopathy. Nephrol Dial Transplant. 1998; 13 (Suppl 4): 39-43.
18. Levin A, Singer J, Thompson CR, Ross H, Lewis M. Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention. Am J Kidney Dis. 1996; 27: 347-354
19. Tucker B, Fabbian F, Giles M, Thuraisingham RC, Raine AI, Baker LR. Left ventricular hypertrophy and ambulatory blood pressure monitoring in chronic renal failure. Nephrol Dial Transplant. 1997; 12: 724-728
20. McGregor E, Jardine AG, Murray LS, Dargie HJ, Rodger RS, Junor BJ, et al. Preoperative echocardiographic abnormalities and adverse outcome following renal transplantation. Nephrol Dial Transplant. 1998; 13: 1499-1505
21. London GM, Pannier B, Guerin AP, Blacher J, Marchais SJ, Darne B, et al. Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study. J Am Soc Nephrol. 2001; 12: 2759-2767
22. Silberberg JS, Barre PE, Prichard SS, Sniderman AD. Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int. 1989; 36: 286-290
23. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol. 1995; 5: 2024-2031
24. de Simone G, Daniels SR, Devereux RB, Meyer RA, Roman MJ, de Divitiis O, et al. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol. 1992; 20: 1251-1260
25. Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Giacone G, Cataliotti A, et al. Prognostic impact of the indexation of left ventricular mass in patients undergoing dialysis. J Am Soc Nephrol. 2001; 12: 2768-2774
26. Foley RN, Parfrey PS, Kent GM, Harnett JD, Murray DC, Barre PE. Serial change in echocardiographic parameters and cardiac failure in end-stage renal disease. J Am Soc Nephrol. 2000; 11: 912-916
27. Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Giacone G, Stancanelli B, et al. Left ventricular mass monitoring in the follow-up of dialysis patients: prognostic value of left ventricular hypertrophy progression. Kidney Int. 2004; 65: 1492-1498 (Pubitemid 38406992)
28. Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray DC, Barre PE. Outcome and risk factors for left ventricular disorders in chronic uremia. Nephrol Dial Transplant. 1996; 11: 1277-1285
29. Barberato SH, Pecoits Filho R. Prognostic value of left atrial volume index in hemodialysis patients. Arq Bras Cardiol. 2007; 88: 643-650
30. Dyadyk OI, Bagriy AI, Yarovaya NF. Disorders of left ventricular structure and function in chronic uremia: how often, why and what to do with it?Eur J Heart Fail. 1999; 1: 327-336
31. Shimizu G, Hirota Y, Kita Y, Kawamura K, Saito T, Gaasch WH. Left ventricular midwall mechanics in systemic arterial hypertension: myocardial function is depressed in pressure-overload hypertrophy. Circulation. 1991; 83: 1676-1684
32. Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Giacone G, Cataliotti A, et al. Prognostic value of echocardiographic indicators of left ventricular systolic function in asymptomatic dialysis patients. J Am Soc Nephrol. 2004;15:1029-1037
33. Oh JK. Echocardiography as a noninvasive Swan-Ganz catheter. Circulation. 2005; 111: 3192-3194
34. Mall G, Huther W, Schneider J, Lundin P, Ritz E. Diffuse intermyocardiocytic fibrosis in uraemic patients. Nephrol Dial Transplant. 1990; 5: 39-44.
35. de Simone G. Left ventricular geometry and hypotension in end-stage renal disease: a mechanical perspective. J Am Soc Nephrol. 2003; 14: 2421-2427
36. Alpert MA. Cardiac performance and morphology in end-stage renal disease. Am J Med Sci. 2003; 325: 168-178
37. Gupta S, Dev V, Kumar MV, Dash SC. Left ventricular diastolic function in end-stage renal disease and the impact of hemodialysis. Am J Cardiol. 1993; 71: 1427-1430
38. Chakko S, Girgis I, Contreras G, Perez G, Kessler KM, Myerburg RJ. Effects of hemodialysis on left ventricular diastolic filling. Am J Cardiol. 1997; 79: 106-108
39. Barberato SH, Mantilla DE, Misocami MA, Goncalves SM, Bignelli AT, Riella MC, et al. Effect of preload reduction by hemodialysis on left atrial volume and echocardiographic Doppler parameters in patients with end-stage renal disease. Am J Cardiol. 2004; 94: 1208-1210
40. Barberato SH, Pecoits Filho R. Influence of preload reduction on Tei index and other Doppler echocardiographic parameters of left ventricular function. Arq Bras Cardiol. 2006; 86: 425-431 (Pubitemid 44033344)
41. Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quinones MA. Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol. 1997; 30: 1527-1533
42. Sohn DW, Chai IH, Lee DJ, Kim HC, Kim HS, Oh BH, et al. Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function. J Am Coll Cardiol. 1997; 30: 474-480
43. Graham RJ, Gelman JS, Donelan L, Mottram PM, Peverill RE. Effect of preload reduction by hAImodialysis on new indices of diastolic function. Clin Sci (Lond). 2003; 105: 499-506. (Pubitemid 37249177)
44. Rakhit DJ, Zhang XH, Leano R, Armstrong KA, Isbel NM, Marwick TH. Prognostic role of subclinical left ventricular abnormalities and impact of transplantation in chronic kidney disease. Am Heart J. 2007; 153: 656-664 (Pubitemid 46440691)
45. Ommen SR, Nishimura RA, Appleton CP, Miller FA, Oh JK, Redfield MM, et al. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study. Circulation. 2000; 102: 1788-1794
46. Dokainish H, Zoghbi WA, Lakkis NM, Al-Bakshy F, Dhir M, Quinones MA, et al. Optimal noninvasive assessment of left ventricular filling pressures: a comparison of tissue Doppler echocardiography and B-type natriuretic peptide in patients with pulmonary artery catheters. Circulation. 2004; 109: 2432-2439 (Pubitemid 38679564)
47. Sharma R, Pellerin D, Gaze DC, Mehta RL, Gregson H, Streather CP, et al Mitral peak Doppler E-wave to peak mitral annulus velocity ratio is an accurate estimate of left ventricular filling pressure and predicts mortality in end-stage renal disease. J Am Soc Echocardiogr. 2006; 19: 266-273 (Pubitemid 43267449)
48. Wang AY, Wang M, Lam CW, Chan IH, Zhang Y, Sanderson JE. Left ventricular filling pressure by Doppler echocardiography in patients with end-stage renal disease. Hypertension. 2008; 52: 107-114
49. Abhayaratna WP, Seward JB, Appleton CP, Douglas PS, Oh JK, Tajik AJ, et al. Left atrial size: physiologic determinants and clinical applications. J Am Coll Cardiol. 2006; 47: 2357-2363
50. Lester SJ, Ryan EW, Schiller NB, Foster E. Best method in clinical practice and in research studies to determine left atrial size. Am J Cardiol. 1999; 84: 829-832 (Pubitemid 29469795)
51. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005; 18: 1440-1463
52. Tsang TS, Abhayaratna WP, Barnes ME, Miyasaka Y, Gersh BJ, Bailey KR, et al. Prediction of cardiovascular outcomes with left atrial size: is volume superior to area or diameter?J Am Coll Cardiol. 2006; 47: 1018-1023
53. Tsang TS, Barnes ME, Gersh BJ, Bailey KR, Seward JB. Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am J Cardiol. 2002; 90: 1284-1289
54. Barberato SH, Pecoits-Filho R. Usefulness of left atrial volume for the differentiation of normal from pseudonormal diastolic function pattern in patients on hemodialysis. J Am Soc Echocardiogr. 2007; 20: 359-365 (Pubitemid 46497621)
55. Tripepi G, Benedetto FA, Mallamaci F, Tripepi R, Malatino L, Zoccali C. Left atrial volume in end-stage renal disease: a prospective cohort study. J Hypertens. 2006; 24: 1173-1180 (Pubitemid 43791075)
56. Wang AY, Woo J, Wang M, Sea MM, Ip R, Li PK, et al. Association of inflammation and malnutrition with cardiac valve calcification in continuous ambulatory peritoneal dialysis patients. J Am Soc Nephrol. 2001; 12: 1927-1936 (Pubitemid 32801369)
57. Wang AY, Wang M, Woo J, Lam CW, Li PK, Lui SF, et al. Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: a prospective study. J Am Soc Nephrol. 2003; 14: 159-168 (Pubitemid 36032720)
58. Sharma R, Chemla E, Tome M, Mehta RL, Gregson H, Brecker SJ, et al. Echocardiography-based score to predict outcome after renal transplantation. Heart. 2007; 93: 464-469 (Pubitemid 46631512)
59. Panuccio V, Tripepi R, Tripepi G, Mallamaci F, Benedetto FA, Cataliotti A, et al. Heart valve calcifications, survival, and cardiovascular risk in hemodialysis patients. Am J Kidney Dis. 2004; 43: 479-484
60. Gunukula SR, Spodick DH. Pericardial disease in renal patients. Semin Nephrol. 2001; 21: 52-56
61. Banerjee A, Davenport A. Changing patterns of pericardial disease in patients with end-stage renal disease. Hemodial Int. 2006; 10: 249-255 (Pubitemid 43923207)
62. Bergeron S, Hillis GS, Haugen EN, Oh JK, Bailey KR, Pellikka PA. Prognostic value of dobutamine stress echocardiography in patients with chronic kidney disease. Am Heart J. 2007; 153: 385-391
63. Rabbat CG, Treleaven DJ, Russell JD, Ludwin D, Cook DJ. Prognostic value of myocardial perfusion studies in patients with end-stage renal disease assessed for kidney or kidney-pancreas transplantation: a meta-analysis. J Am Soc Nephrol. 2003; 14: 431-439
64. De Lima JJ, Sabbaga E, Vieira ML, de Paula FJ, Ianhez LE, Krieger EM, et al. Coronary angiography is the best predictor of events in renal transplant candidates compared with noninvasive testing. Hypertension. 2003;42:263-268
65. Dahan M, Viron BM, Poiseau E, Kolta AM, Aubry N, Paillole C, et al. Combined dipyridamole-exercise stress echocardiography for detection of myocardial ischemia in hemodialysis patients: an alternative to stress nuclear imaging. Am J Kidney Dis. 2002; 40: 737-744
66. Cortigiani L, Desideri A, Gigli G, Vallebona A, Terlizzi R, Giusti R, et al. Clinical, resting echo and dipyridamole stress echocardiography findings for the screening of renal transplant candidates. Int J Cardiol. 2005; 103: 168-174
67. Ferreira PA, de Lima VC, Campos Filho O, Gil MA, Cordovil A, Machado CV, et al. Feasibility, safety and accuracy of dobutamine/atropine stress echocardiography for the detection of coronary artery disease in renal transplant candidates. Arq Bras Cardiol. 2007; 88: 45-51.
68. K/DOQI Workgroup. Clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis. 2005; 45: S1-153.